Deferoxamine Mesylate and Linagliptin and Metformin Extended-Release Tablets
Determining the interaction of Deferoxamine Mesylate and Linagliptin and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deferoxamine
Brand name: Desferal
Synonyms: Deferoxamine
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and metformin, Linagliptin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deferoxamine Mesylate-Linagliptin and Metformin Tablets
- Deferoxamine Mesylate-Lincocin
- Deferoxamine Mesylate-Lincomycin
- Deferoxamine Mesylate-Lincomycin Hydrochloride
- Deferoxamine Mesylate-Lincomycin Injection
- Deferoxamine Mesylate-Lincomycin Oral, Injection
- Linagliptin and Metformin Extended-Release Tablets-Defibrotide
- Linagliptin and Metformin Extended-Release Tablets-Defibrotide Intravenous
- Linagliptin and Metformin Extended-Release Tablets-Defibrotide Sodium
- Linagliptin and Metformin Extended-Release Tablets-Definity
- Linagliptin and Metformin Extended-Release Tablets-Defitelio
- Linagliptin and Metformin Extended-Release Tablets-Deflazacort